Neuropore Therapies, Inc. is a San Diego, California based biopharmaceutical company developing novel disease modifying small molecule therapeutics for the treatment of Parkinson’s disease and other neurodegenerative disorders by targeting underlying mechanisms related to protein pathology and neuroinflammation.
